Follow
Patricia Biedermann
Patricia Biedermann
Evidence Generation Lead, Takeda Pharmaceuticals
Verified email at takeda.com - Homepage
Title
Cited by
Cited by
Year
Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis
YS Lai, P Biedermann, UF Ekpo, A Garba, E Mathieu, N Midzi, P Mwinzi, ...
The Lancet Infectious Diseases 15 (8), 927-940, 2015
2422015
Spatial and temporal distribution of soil-transmitted helminth infection in sub-Saharan Africa: a systematic review and geostatistical meta-analysis
DA Karagiannis-Voules, P Biedermann, UF Ekpo, A Garba, E Langer, ...
The Lancet infectious diseases 15 (1), 74-84, 2015
1962015
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled …
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
medRxiv, 2020
1772020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
The Lancet Rheumatology, 2020
1262020
Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases
P Biedermann, R Ong, A Davydov, A Orlova, P Solovyev, H Sun, ...
BMC medical research methodology 21 (1), 1-16, 2021
402021
Geostatistical modelling of soil-transmitted helminth infection in Cambodia: do socioeconomic factors improve predictions?
DA Karagiannis-Voules, P Odermatt, P Biedermann, V Khieu, F Schär, ...
Acta tropica 141, 204-212, 2015
342015
Risk profiling of soil-transmitted helminth infection and estimated number of infected people in South Asia: A systematic review and Bayesian geostatistical Analysis
YS Lai, P Biedermann, A Shrestha, F Chammartin, N à Porta, A Montresor, ...
PLoS neglected tropical diseases 13 (8), e0007580, 2019
252019
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
Rheumatology 60 (7), 3222-3234, 2021
212021
Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study
TJ Lange, S Söderberg, P Biedermann, A Muller, K Luik, P Escribano, ...
TP82. TP082 LET IT BE-CLINICAL ADVANCES IN PULMONARY VASCULAR DISEASE: PAH …, 2021
32021
Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH)
S Gaine, P Escribano, P Biedermann, A Muller, H Sun, S Söderberg, ...
European Respiratory Journal 58 (suppl 65), 2021
22021
CONTEMPORARY TREATMENT PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: INSIGHT FROM THE OBSERVATIONAL EXPOSURE STUDY
S Söderberg, S Gaine, P Biedermann, A Muller, H Sun, T Lange, ...
Chest 158 (4), A2259-A2260, 2020
22020
Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
TJ Lange, P Escribano, P Biedermann, A Muller, H Sun, S Söderberg, ...
B27. UP-TO-DATE PAH ASSESSMENT AND MANAGEMENT, A2910-A2910, 2020
22020
Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
medRxiv, 2020
22020
Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
P Escribano, S Gaine, P Biedermann, A Muller, M Valge, T Lange, ...
The Journal of Heart and Lung Transplantation 40 (4), S109, 2021
12021
S79 Selexipag titration and dosing patterns in patients with pulmonary arterial hypertension (PAH) in a real-world clinical setting: insights from the EXPOSURE study
MK Johnson, TJ Lange, S Söderberg, P Biedermann, A Muller, K Luik, ...
Thorax 76 (Suppl 2), A50-A51, 2021
2021
Standardisation of disease registry data to the OMOP common data model: The pulmonary hypertension experience-Challenges and achievements
P Biedermann, A Davydov, A Orlova, R Ong, G Wetherill, EM Didden
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 336-336, 2020
2020
Risk status at selexipag initiation in pulmonary arterial hypertension (PAH): Insights from EXPOSURE
S Gaine, P Escribano, P Biedermann, A Muller, H Sun, S Söderberg, ...
European Respiratory Journal 56 (suppl 64), 2020
2020
Standardisation Of Disease Registry Data To The OMOP Common Data Model: The Pulmonary Hypertension Experience - Challenges And Achievements
GWEMD Patricia Biedermann, Alexander Davydov, Alexandra Orlova, Rose Ong
ISPE, 2020
2020
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled …
P Rijnbeek, JCE Lane, SMK Sathappan, J Weaver, M Schuemie, K Kostka, ...
2020
REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE)
A Muller, S Söderberg, P Escribano, P Biedermann, H Sun, TJ Lange, ...
ISPOR 2019 22 (3), S602-S603, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20